Theodore Levin to Adult
This is a "connection" page, showing publications Theodore Levin has written about Adult.
Connection Strength
0.546
-
Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. Clin Gastroenterol Hepatol. 2012 Jan; 10(1):37-45.
Score: 0.041
-
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006 Dec 19; 145(12):880-6.
Score: 0.030
-
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Netw Open. 2024 Jul 01; 7(7):e2421019.
Score: 0.025
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. Ann Intern Med. 2024 Apr; 177(4):542-543.
Score: 0.025
-
What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
Score: 0.024
-
Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):22-29.
Score: 0.023
-
Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
Score: 0.019
-
Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Ann Intern Med. 2019 07 02; 171(1):19-26.
Score: 0.018
-
Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol. 1998 Jul; 93(7):1060-3.
Score: 0.016
-
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8.
Score: 0.016
-
Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997 Dec; 103(6):520-8.
Score: 0.016
-
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul; 112(7):1016-1030.
Score: 0.015
-
Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007 Jun; 56(6):756-62.
Score: 0.015
-
Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4.
Score: 0.013
-
Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
Score: 0.013
-
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
Score: 0.012
-
Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep; 125(3):668-76.
Score: 0.012
-
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
Score: 0.011
-
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9.
Score: 0.011
-
Lack of association between insulin sensitivity and colorectal adenoma risk. Nutr Cancer. 2011; 63(1):6-11.
Score: 0.010
-
Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):42-48.e1.
Score: 0.009
-
Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
Score: 0.008
-
Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
Score: 0.008
-
Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
Score: 0.008
-
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 07; 149(7):441-50, W81.
Score: 0.008
-
Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
Score: 0.008
-
Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
Score: 0.008
-
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
Score: 0.008
-
Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
Score: 0.008
-
Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
Score: 0.008
-
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
Score: 0.008
-
Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
Score: 0.008
-
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis. 2007 Aug; 28(8):1672-9.
Score: 0.008
-
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer. 2007 Feb 01; 120(3):656-63.
Score: 0.007
-
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol. 2006 Jul; 4(7):894-901.
Score: 0.007
-
Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
Score: 0.007
-
PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control. 2006 Apr; 17(3):239-49.
Score: 0.007
-
Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003 Nov; 14(9):879-87.
Score: 0.006
-
A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Arch Intern Med. 2003 May 26; 163(10):1165-71.
Score: 0.006
-
Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
Score: 0.005
-
Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology. 2002 Apr; 122(4):940-7.
Score: 0.005
-
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol. 2002 Mar; 55(3):310-3.
Score: 0.005
-
Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000 May; 27(4):623-30.
Score: 0.005
-
Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000 Mar; 95(3):788-92.
Score: 0.005
-
Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries. Catheter Cardiovasc Interv. 2000 Feb; 49(2):121-6.
Score: 0.005
-
Cardiac exposure history as a determinant of symptoms and emergency department utilization in noncardiac chest pain patients. J Behav Med. 1999 Dec; 22(6):605-17.
Score: 0.005
-
Spontaneous peritonitis caused by Streptococcus bovis. J Clin Gastroenterol. 1994 Dec; 19(4):346.
Score: 0.003